TAVR Market Leads Heart Health Revolution with Surging Innovations

The global transcatheter aortic valve replacement (TAVR) market size is expected to be valued at USD 4.28 billion in 2024 and reach USD 10.02 billion by 2029, growing at a CAGR of 18.50 % from 2024 to 2029.

Transcatheter aortic valve replacement is a procedure that replaces a diseased aortic valve with a transcatheter aortic valve, which regenerates the blood-pumping function of the heart aortic valve.

Global TAVR Market Report Scope:
• Market Size (2029): USD 10.02 Billion
• Market Size (2024): USD 4.28 Billion
• CAGR (2024 to 2029): 18.50 %
• Base Year: 2023
• Forecast Period: 2024 to 2029
• Segments Analysed: Surgery Method, Valve Frame Material, Valve Size, Valve Leaflets Material, End Users and Region.
• Geographies Covered: North America, Europe, APAC, Latin America, and Middle East & Africa.
• Key Market Players Profiled Edwards Lifesciences Corporation (U.S.), Medtronic, Inc. (Ireland), Boston Scientific Corporation (U.S.), Abbott Laboratories (U.S.), St. Jude Medical Inc. (U.S.), JenaValve Technology, Inc. (Germany), Symetis SA (Switzerland), Direct Flow Medical, Inc. (U.S.), Sorin Group (Italy), Meril Life Sciences India Pvt Ltd (India) and Braile Biomedica (Brazil). Are playing a dominant role in the global transcatheter aortic valve replacement (TAVR) market.

The increasing demand for minimally invasive procedures across the globe as these replace traditional surgical procedures, leading to shorter hospital stays with rapid recovery time, is driving the global transcatheter aortic valve replacement market growth as the TAVR is a minimally invasive technique, the post-operative complications are expected to be low chances, influencing healthcare professionals and patients to choose this method by escalating the market revenue worldwide. The growing investments in clinical trials by the market players to expand the indications for TAVR in low-risk patients fuels the market growth opportunities during the forecast period. The ongoing clinical trials focus on evaluating the safety and efficacy of the procedure in patients, which will expand the market size. In the initial stages, the TAVR is used in patients with extreme risk for surgery. However, the device design became more efficient with the support of clinical trial data and expanded the indications for the TAVR procedure. According to Cardiovascular Business magazine, in 2021, 92,000 TAVR valves were implanted in patients only in the United States. The rising senior population worldwide with chronic cardiovascular diseases is demanding that TAVR techniques propel the adoption rate globally. The increasing marketing strategies of the market players contribute to the market expansion. The growing government initiatives for raising awareness among the people regarding the best treatment options with low-risk effects and assurance of reimbursement policies due to clinical evidence are estimated to augment the global market share. Several research publications have concluded that second-generation TAVR devices have better safety-related benefits. The escalating lifestyle disorders among the world population where cardiovascular diseases are more frequent induce aortic stenosis, accelerating demand for the TAVR market growth.

The high cost associated with transcatheter aortic valves significantly restraining the global transcatheter aortic valve replacement market growth. The expensive technique is difficult to afford for people from low and middle economies, hindering market expansion. Accessibility to the TAVR technique is limited in specific regions due to the requirement of specialized centers or the absence of advanced healthcare infrastructure, which limits the global market revenue. The reimbursement policies vary across regions and healthcare systems, which can be limited in low-income regions, hampering the global market.

Browse full details of the report @ https://www.marketdataforecast.com/market-reports/transcatheter-aortic-valve-replacement-market

Key Insights from The Report:
• Based on surgery method, the transfemoral implantation segment led the market and accounted for the largest share of the global market in 2023.
• Based on valve frame material, the nitinol segment held the second largest share of the global market in 2023.
• North America dominated the transcatheter aortic valve replacement (TAVR) market in 2023. Europe accounted for second-highest share of the global market in 2023 and on the other hand, the Asia-Pacific region is estimated to grow at the fastest CAGR during the forecast period.
• Profiled Edwards Lifesciences Corporation (U.S.), Medtronic, Inc. (Ireland), Boston Scientific Corporation (U.S.), Abbott Laboratories (U.S.), St. Jude Medical Inc. (U.S.), JenaValve Technology, Inc. (Germany), Symetis SA (Switzerland), Direct Flow Medical, Inc. (U.S.), Sorin Group (Italy), Meril Life Sciences India Pvt Ltd (India) and Braile Biomedica (Brazil). are dominated the transcatheter aortic valve replacement (TAVR) market.

SEGMENTATION INCLUDED IN THIS REPORT:
By Surgery Method:
• Transfemoral Implantation
• Transapical Implantation
• Transaortic Implantation
• Transcaval Implantation
By Valve Frame Material:
• Nitinol
• Stainless Steel
• Cobalt-Chromium
By Valve Size:
• 14mm to 18 mm
• 18mm to 22 mm
• 22mm to 29mm
By Valve Leaflets Material:
• Bovine Heart Tissue
• Cow Heart Tissue
• Other Valve Leaflets Material
By End - User:
• Hospitals
• Ambulatory Surgical Centres
• Cardiac Catheterization Laboratories
By Region:
• North America
• Europe
• Asia-Pacific
• Latin America
• Middle East and Africa

Browse Regional Reports:
North America Transcatheter Aortic Valve Replacement Market Research Report - Segmented By Surgery Method, Valve Frame Material, Valve Size, Valve Leaflets Material, End Users & Country (United States, Canada, Mexico & Rest of North America) - Industry Analysis on Size, Share, Trends, COVID-19 Impact & Growth Forecast (2024 to 2029) - https://www.marketdataforecast.com/market-reports/na-transcatheter-aortic-valve-replacement-market
Europe Transcatheter Aortic Valve Replacement Market Research Report - Segmented By Surgery Method, Valve Frame Material, Valve Size, Valve Leaflets Material, End Users & Country (UK, France, Spain, Germany, Italy, Russia, Sweden, Denmark, Switzerland, Netherlands, Turkey, Czech Republic and Rest of Europe) - Industry Analysis on Size, Share, Trends, COVID-19 Impact & Growth Forecast (2024 to 2029) - https://www.marketdataforecast.com/market-reports/eu-transcatheter-aortic-valve-replacement-market
Asia-Pacific Transcatheter Aortic Valve Replacement Market Research Report - Segmented By Surgery Method, Valve Frame Material, Valve Size, Valve Leaflets Material, End Users & Country (India, China, Japan, South Korea, Australia, New Zealand, Thailand, Malaysia, Vietnam, Philippines, Indonesia, Singapore and Rest of APAC) - Industry Analysis, Size, Share, Trends & Growth Forecast (2024 to 2029) - https://www.marketdataforecast.com/market-reports/apac-transcatheter-aortic-valve-replacement-market
Latin America Transcatheter Aortic Valve Replacement Market Research Report - Segmented By Surgery Method, Valve Frame Material, Valve Size, Valve Leaflets Material, End Users & Country (Brazil, Argentina, Chile and Rest of Latin America) - Industry Analysis on Size, Share, Trends, COVID-19 Impact & Growth Forecast (2024 to 2029) - https://www.marketdataforecast.com/market-reports/la-transcatheter-aortic-valve-replacement-market
Middle East & Africa Transcatheter Aortic Valve Replacement Market Research Report - Segmented By Surgery Method, Valve Frame Material, Valve Size, Valve Leaflets Material, End Users & Country (KSA, UAE, Israel, rest of GCC countries, South Africa, Ethiopia, Kenya, Egypt, Sudan, rest of MEA) - Industry Analysis on Size, Share, Trends, COVID-19 Impact & Growth Forecast (2024 to 2029) - https://www.marketdataforecast.com/market-reports/mea-transcatheter-aortic-valve-replacement-market

TABLE OF CONTENTS:
1. Introduction
1.1 Market Definition
1.2 Study Deliverables
1.3 Base Currency, Base Year and Forecast Periods
1.4 General Study Assumptions
2. Research Methodology
2.1 Introduction
2.2 Research Phases
2.2.1 Secondary Research
2.2.2 Primary Research
2.2.3 Econometric Modelling
2.2.4 Expert Validation
2.3 Analysis Design
2.4 Study Timeline
3. Overview
3.1 Executive Summary
3.2 Key Inferences
3.3 Epidemology
4. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)
4.1 Market Drivers
4.2 Market Restraints
4.3 Key Challenges
4.4 Current Opportunities in the Market
5. Market Segmentation
5.1 Product
5.1.1 Introduction
5.1.2 Hearing AID Devices
5.1.2.1 Receiver-In-The-Ear (RITE) Hearing AIDS
5.2.2.2 Behind-The-Ear (BTE) Hearing AIDS
5.2.2.3 Canal Hearing AIDS
5.2.2.4 In-The-Ear (ITE) Hearing AIDS
5.2.2.5 Other Hearing AIDS
5.1.3 Hearing Implants
5.1.3.1 Cochlear Implants
5.1.3.2 Bone-Anchored Systems
5.1.4 Y-o-Y Growth Analysis, By Product
5.1.5 Market Attractiveness Analysis, By Product
5.1.6 Market Share Analysis, By Product
5.2 Type of Hearing Loss
5.2.1 Introduction
5.2.2 Sensorineural Hearing Loss
5.2.3 Conductive Hearing Loss
5.2.4 Y-o-Y Growth Analysis, By Type of Hearing Loss
5.2.5 Market Attractiveness Analysis, By Type of Hearing Loss
5.2.6 Market Share Analysis, By Type of Hearing Loss
5.3 End User
5.3.1 Introduction
5.3.2 Adults
5.3.3 Pediatrics
5.3.4 Y-o-Y Growth Analysis, By End User
5.3.5 Market Attractiveness Analysis, By End User
5.3.6 Market Share Analysis, By End User
6. Geographical Analysis
6.1 Introduction
6.1.1 Regional Trends
6.1.2 Impact Analysis
6.1.3 Y-o-Y Growth Analysis
6.1.3.1 By Geographical Area
6.1.3.2 By Product
6.1.3.3 By Type of Hearing Loss
6.1.3.4 By End User
6.1.4 Market Attractiveness Analysis
6.1.4.1 By Geographical Area
6.1.4.2 By Product
6.1.4.3 By Type of Hearing Loss
6.1.4.4 By End User
6.1.5 Market Share Analysis
6.1.5.1 By Geographical Area
6.1.5.2 By Product
6.1.5.3 By Type of Hearing Loss
6.1.5.4 By End User
6.2 North America
6.1.1 Introduction
6.1.2 United States
6.1.3 Canada
6.3 Europe
6.2.1 Introduction
6.2.2 U.K
6.2.3 Spain
6.2.4 Germany
6.2.5 Italy
6.2.6 France
6.4 Asia-Pacific
6.3.1 Introduction
6.3.2 China
6.3.3 India
6.3.4 Japan
6.3.5 Australia
6.3.6 South Korea
6.5 Latin America
6.4.1 Introduction
6.4.2 Brazil
6.4.3 Argentina
6.4.4 Mexico
6.4.5 Rest of Latin America
6.6 Middle East & Africa
6.5.1 Introduction
6.5.2 Middle-East
6.5.3 Africa
7. Strategic Analysis
7.1 PESTLE analysis
7.1.1 Political
7.1.2 Economic
7.1.3 Social
7.1.4 Technological
7.1.5 Legal
7.1.6 Environmental
7.2 Porter's Five analysis
7.2.1 Bargaining Power of Suppliers
7.2.2 Bargaining Power of Consumers
7.2.3 Threat of New Entrants
7.2.4 Threat of Substitute Products and Services
7.2.5 Competitive Rivalry within the Industry
8. Market Leaders' Analysis
8.1 Sonova Holding Ag
8.1.1 Overview
8.1.2 Product Analysis
8.1.3 Financial analysis
8.1.4 Recent Developments
8.1.5 SWOT analysis
8.1.6 Analyst View
8.2 William Demant Holding A/S
8.3 GN Store Nord A/S
8.4 Cochlear Limited
8.5 Sivantos Pte. Ltd.
8.6 Starkey Hearing Technologies, Inc.
8.7 Widex
8.8 Med-El
8.9 Zounds Hearing, Inc.
8.10 Sebotek Hearing Systems, Llc
9. Competitive Landscape
9.1 Market share analysis
9.2 Merger and Acquisition Analysis
9.3 Agreements, collaborations and Joint Ventures
9.4 New Product Launches
10. Market Outlook and Investment Opportunities
Appendix
a) List of Tables
b) List of Figures

Contact Us:
Market Data Forecast
www.marketdataforecast.com
Phone: +1-888-702-9626
Email: sales@marketdataforecast.com
5th Floor, Trendz Pride, Patrika Nagar Rd Number 1, HUDA Techno Enclave, HITEC City, Hyderabad, Telangana 500081, India

Market Data Forecast is a firm working in the areas of market research, business intelligence and consulting. We have rich experience in research and consulting for various business domains to cater to the needs of both individual and corporate clients.

This release was published on openPR.